113. Muscular dystrophy Clinical trials / Disease details
Clinical trials : 646 / Drugs : 471 - (DrugBank : 105) / Drug target genes : 59 - Drug target pathways : 170
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02972580 (ClinicalTrials.gov) | June 2016 | 25/7/2016 | Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD | Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) | Duchenne Muscular Dystrophy;Becker Muscular Dystrophy | Genetic: Genetic characterization | Nationwide Children's Hospital | Parent Project Muscular Dystrophy | Active, not recruiting | 18 Years | N/A | Female | 250 | United States |